by Richard Daverman, PhD ChinaBio Today China biopharma stocks listed on US exchanges weathered a difficult first quarter of 2008. The ChinaBio® Stock Index fell from 1675 to 1215 during the three months, a substantial decline of 27.4%. During...
(click article title to read more...)
